南模生物 (688265.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

32.0x

Market Cap

CNY 3.12B

MomentumView details →

1D Return

−5.37%

YTD Return

—

RSI (14)

45.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

32.0x

Market Cap

CNY 3.12B

RSI (14)

45.1

MomentumView details →

1D Return

−5.37%

YTD Return

—

ProfitabilityView details →

Gross Margin

52.77%

Net Margin

7.65%

EBITDA Margin

19.52%

ROE (TTM)

1.93%

ROA (TTM)

1.68%

Asset Turnover

0.22x

GrowthView details →

Revenue YoY

+11.85%

EPS YoY

+86.93%

FCF YoY

−54.15%

Revenue CAGR 3Y

+11.59%

EPS CAGR 3Y

+425.00%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

5.83x

Quick Ratio

5.69x

Div Yield

0.33%

Div Rate

CNY 0.13

Div Growth 1Y

−4.14%

Financials snapshotView financials →

Revenue (TTM)

432.55M

Net Income (TTM)

33.09M

Op. CF (TTM)

88.29M

Next earningsOct 29, 2026 →

Latest newsMore news →

The Shanghai Stock Exchange issued a regulatory work letter to Shanghai Model Organisms regarding certain matters.15d ago

Similar companies

Celldex Therapeutics, Inc.CLDX Jiangsu Recbio Technology Co., Ltd.02179.HK 凯因科技688687.SH Beam Therapeutics Inc.BEAM Immunome, Inc.IMNM Disc Medicine, Inc.IRON Find similar companies →

Latest newsMore news →

The Shanghai Stock Exchange issued a regulatory work letter to Shanghai Model Organisms regarding certain matters.15d ago